Brainstorm Cell Therapeutics Inc. Reports Q2 2026 Results

What Happened

• Brainstorm Cell Therapeutics Inc. announced its quarterly financial results for the quarter ended June 30, 2026 via a press release dated August 14, 2026. The company furnished the press release as Exhibit 99.1 to a Form 8-K filed on August 14, 2026 under Item 2.02 (Results of Operations and Financial Condition).

Key Details

• Filing date: August 14, 2026 (Form 8-K).
• Reporting period: Quarter ended June 30, 2026.
• Press release furnished as Exhibit 99.1 to the Form 8-K.
• The Form 8-K also includes the cover page interactive data file (Inline XBRL) as required under Item 9.01.

Why It Matters

• This 8-K signals that Brainstorm has released its latest quarterly earnings and other financial metrics; investors should review the Exhibit 99.1 press release for the company’s reported revenue, net income/loss, cash position, and any operational updates or guidance.
• Because the information was furnished in an 8-K, it provides timely disclosure of quarterly results that can affect near-term valuation and investment decisions.